PUBLICATIONS

Références et publications

Tous les liens de cette page renvoient vers des résumés d’articles (abstracts). L’ensemble des versions intégrales sont disponibles au Centre de Psychiatrie Interventionnelle.

Psychiatrie interventionnelle en Suisse

Société Suisse de Psychiatrie Interventionnelle (SSPI)

Autres spécialistes : Dr Fady Rachid (Genève, TMS) · Dr Michael Fischer (Zürich, TMS et autres techniques)

DEXDexmédétomidine, dépression et anxiété

▼

Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review.

Al-Mahrouqi T et al. Clin Pract Epidemiol Ment Health. 2023;19:e174501792307240

Antidepressant effects of dexmedetomidine compared with ECT in patients with treatment-resistant depression.

Liu Y et al. J Affect Disord. 2023;347:437-444

Anesthetics as Treatments for Depression: Clinical Insights and Underlying Mechanisms.

Breault MS et al. Annu Rev Neurosci. 2025;48(1):103-124

Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties.

Bosch OG et al. Pharmacopsychiatry. 2022;56(2):44-50

N₂OProtoxyde d’azote et dépression

▼

Nitrous oxide for late-life depression with inadequate antidepressant response: a randomised controlled trial.

Salamé A, Bulteau S, Robert G, et al. EClinicalMedicine. 2026;94:103860

No Laughing Matter: Nitrous Oxide and Depression.

Williams E, Cowen PJ. Biol Psychiatry Glob Open Sci. 2025;5(5):100551

Nitrous oxide for the treatment of psychiatric disorders: A systematic review of the clinical trial landscape

Liu H et al. Acta Psychiatr Scand. 2022;146(2):126-138

The evolution of NMDA receptor antagonists as antidepressant agents.

Kalmoe MC et al. J Neurol Sci. 2020;412:116778

Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis.

de Leon VC et al. J Clin Psychiatry. 2023;84(5)

The efficacy and tolerability of inhaled nitrous oxide in major depressive disorder: a systematic review and meta‑analysis.

Qiu Y et al. Psychopharmacology (Berl). 2023;240(10):2033-2043

Mini-Review: A Brief History of Nitrous Oxide (N2O) Use in Neuropsychiatry.

Gillman MA. Curr Drug Res Rev. 2019;11(1):12-20

Exploring Nitrous Oxide as Treatment of Mood Disorders: Basic Concepts.

Nagele P et al. J Clin Psychopharmacol. 2018;38(2):144-148

Nitrous Oxide: an emerging novel treatment for treatment-resistant depression.

Quach DF et al. J Neurol Sci. 2021;434:120092

Safety and efficacy of an equimolar mixture of oxygen and nitrous oxide: a randomized controlled trial in patients with peripheral neuropathic pain.

Bouhassira D et al. Pain. 2021;162(4):1104-1115

A phase 2 trial of inhaled nitrous oxide for treatment-resistant major depression.

Nagele P et al. Sci Transl Med. 2021;13(597)

Le gaz hilarant serait redoutablement efficace pour soigner la dépression

(Ça m’intéresse)

TMSInformations générales sur la TMS

▼

tms-therapie.ch

TMS-Thérapie

TMSEfficacité et sécurité de la TMS

▼

Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). (Clinical Neurophysiology

Lefaucheur JP et al. Clin Neurophysiol. 2014;125(11):2150-2206

Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines.

Rossi S et al. Clin Neurophysiol. 2020;132(1):269-306

Clinical Neurophysiology

Rossi S et al. Clin Neurophysiol. 2020;132(1):269-306

TMSEfficacité de la TMS dans la dépression

▼

Dose-response associations of total pulse dose and intersession interval with clinical outcomes in accelerated rTMS for major depressive episodes: A systematic review and meta-analysis.

Wang VX-Y, Mehta DD, Downar J, et al. Brain Stimul. 2026;19:103129

The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.

Perera T et al. Brain Stimul. 2016;9(3):336-346

Repetitive transcranial magnetic stimulation for depression, NICE interventional procedure guidance [IPG542]. (National Institute for Health and Care Excellence)

NICE

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.

O’Reardon JP et al. Biol Psychiatry. 2007;62(11):1208-16

Comparative efficacy and acceptability of neuromodulation procedures in the treatment of treatment-resistant depression: a network meta-analysis of randomized controlled trials.

Li H et al. J Affect Disord. 2021;287:115-124

Transcranial magnetic stimulation for geriatric depression: Promises and pitfalls

Sabesan P et al. World J Psychiatry. 2015;5(2):170-81

Intensive HF-rTMS treatment in refractory medication-resistant unipolar depressed patients. (Journal of Affective Disorders)

Baeken C et al. J Affect Disord. 2013;151(2):625-631

Consensus Review and Considerations on TMS to Treat Depression: A Comprehensive Update

Trapp NT, Purgianto A, Taylor JJ, et al. Clin Neurophysiol. 2025;169:110627

Efficacy and Safety of Transcranial Magnetic Stimulation for Treating Major Depressive Disorder: An Umbrella Review and Re-Analysis of Published Meta-Analyses

Brini S, Brudasca NI, Hodkinson A, et al. Clin Psychol Rev. 2023;100:102236

Novel and emerging treatments for major depression

Marwaha S, Palmer E, Suppes T, et al. Lancet. 2023;401(10371):141-153

Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression (FOUR-D)

Blumberger DM, Mulsant BH, Thorpe KE, et al. JAMA Psychiatry. 2022;79(11):1065-1073

Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial

Blumberger DM, Vila-Rodriguez F, Thorpe KE, et al. Lancet. 2018;391(10131):1683-1692

Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression

McClintock SM, Reti IM, Carpenter LL, et al. J Clin Psychiatry. 2018;79(1):16cs10905

Comparison between accelerated and standard or sham repetitive transcranial magnetic stimulation in the treatment of depression: A systematic review

Lefaucheur JP, Colzi C, Hollander E, et al. Neurosci Biobehav Rev. 2025;169:106018

Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis

Brunoni AR, Chaimani A, Moffa AH, et al. JAMA Psychiatry. 2017;74(2):143-152

Neuromodulation Strategies for the Treatment of Depression

Conroy SK, Holtzheimer PE. Am J Psychiatry. 2021;178(12):1082-1088

Efficacy of repetitive transcranial magnetic stimulation (rTMS) adjunctive therapy for major depressive disorder (MDD) after two antidepressant treatment failures: meta-analysis

Vida RG, Sághy E, Bella R, et al. BMC Psychiatry. 2023;23(1):545

The association between sample and treatment characteristics and the efficacy of repetitive transcranial magnetic stimulation in depression: A meta-analysis and meta-regression of sham-controlled trials

Dalhuisen I, van Bronswijk S, Bors J, et al. Neurosci Biobehav Rev. 2022;141:104848

Optimal parameter determination of repetitive transcranial magnetic stimulation for treating treatment-resistant depression: A network meta-analysis of randomized controlled trials

Li J, Cui L, Li H, et al. Front Psychiatry. 2022;13:1038312

TMSEfficacité de la TMS dans d’autres indications

▼

Transcranial magnetic stimulation of dorsolateral prefrontal cortex reduces cocaine use: A pilot study

Terraneo A et al. Eur Neuropsychopharmacol. 2015;26(1):37-44

Repetitive transcranial magnetic stimulation in chronic pain: a review of the literature.

Galhardoni R et al. Arch Phys Med Rehabil. 2014;96(4 Suppl):S156-72

Long-term maintenance of the analgesic effects of transcranial magnetic stimulation in fibromyalgia.

Mhalla A et al. Pain. 2011;152(7):1478-1485

Review of the effectiveness of transcranial magnetic stimulation for post-traumatic stress disorder.

Karsen EF et al. Brain Stimul. 2013;7(2):151-7

An Update of the Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients with Obsessive Compulsive Disorder

J Neuropsychiatry

Repetitive transcranial magnetic stimulation for obsessive-compulsive disorder: A systematic review and pairwise/network meta-analysis.

Fitzsimmons SMDD et al. J Affect Disord. 2022;302:302-312

A pilot study of fMRI targeted rTMS for obsessive compulsive disorder.

Fitzgerald PB et al. Brain Stimul. 2022;15(2):483-484

Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial.

Lien

Repetitive Transcranial Magnetic Stimulation for Phantom Limb Pain in Land Mine Victims: A Double-Blinded, Randomized, Sham-Controlled Trial.

Malavera A et al. J Pain. 2016;17(8):911-8

Brain Stimulation in Alzheimer’s Disease. (Frontiers in Psychiatry)

Chang CH et al. Front Psychiatry. 2018;9:201

Repetitive transcranial magnetic stimulation combined with cognitive training for the treatment of Alzheimer’s disease.

Nguyen JP et al. Neurophysiol Clin. 2017;47(1):47-53

Neuromodulation for the treatment of eating disorders and obesity.

Lee DJ et al. Ther Adv Psychopharmacol. 2017;8(2):73-92

Repetitive Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: A Systematic Review and Pairwise/Network Meta-Analysis

Fitzsimmons SMDD, van der Werf YD, van Campen AD, et al. J Affect Disord. 2022;302:302-312

The Efficacy and Acceptability of Non-Invasive Brain Stimulation Interventions for Obsessive-Compulsive Disorder Management: A Network Meta-Analysis Based on 24 Stimulation Methods

Tseng PT, Hsu CW, Hung CM, et al. Acta Psychiatr Scand. 2025;152(2):140-155

Deep Transcranial Magnetic Stimulation for Treatment-Resistant Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized-Controlled Trials

Li K, Qian L, Zhang C, et al. J Psychiatr Res. 2024;180:274-280

Symptom Provocation and Clinical Response to Transcranial Magnetic Stimulation

Bello D, Jones M, Gadiyar I, et al. JAMA Psychiatry. 2025;82(8):773-782

Repetitive Transcranial Magnetic Stimulation (R-TMS) and Selective Serotonin Reuptake Inhibitor-Resistance in Obsessive-Compulsive Disorder: A Meta-Analysis and Clinical Implications

Pellegrini L, Garg K, Enara A, et al. Compr Psychiatry. 2022;118:152345

The Efficacy of Transcranial Magnetic Stimulation in the Treatment of Obsessive-Compulsive Disorder: An Umbrella Review of Meta-Analyses

Kar SK, Agrawal A, Silva-Dos-Santos A, Gupta Y, Deng ZD. CNS Spectr. 2024;29(2):79-89

Efficacy and Tolerability of Repetitive Transcranial Magnetic Stimulation for the Treatment of Obsessive-Compulsive Disorder in Adults: A Systematic Review and Network Meta-Analysis

Liang K, Li H, Bu X, et al. Transl Psychiatry. 2021;11(1):332

Metaanalysis of Repetitive Transcranial Magnetic Stimulation (rTMS) Efficacy for OCD Treatment: The Impact of Stimulation Parameters, Symptom Subtype and rTMS-Induced Electrical Field

Dehghani-Arani F, Kazemi R, Hallajian AH, et al. J Clin Med. 2024;13(18):5553

ECTEfficacité de l’ECT dans la dépression

▼

Diverging Trajectories of Depressive Symptoms During Electroconvulsive Therapy: Toward Personalized Treatment.

Sellevåg K, Bartz-Johannessen CA, Oedegaard KJ, et al. Biol Psychiatry Glob Open Sci. 2026;6(4):100722

Systematic review on relapse-prevention strategies following successful electroconvulsive therapy for major depressive disorder.

Rovers JJE, van Zeijl NT, Tendolkar I, Dols A, van Eijndhoven PFP. BJPsych Open. 2026;12:e37

Le renouveau des électrochocs

UNIL

Antidepressant pharmacotherapy failure and response to subsequent electroconvulsive therapy: a meta-analysis.

Heijnen WT et al. J Clin Psychopharmacol. 2010;30(5):616-9

Relapse Following Successful Electroconvulsive Therapy For Major Depression: A Meta- Analysis

Jelovac A et al. Neuropsychopharmacology. 2013;38(12):2467-74

Maintenance electroconvulsive therapy up to 12 years.

Elias A et al. J Affect Disord. 2013;156:228-31

Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication.

Spaans HP et al. Br J Psychiatry. 2014;206(1):67-71

Electroconvulsive Therapy in the Elderly: New Findings in Geriatric Depression.

Geduldig ET, Kellner CH. Curr Psychiatry Rep. 2016;18(4):40

Improvements in Health-Related Quality of Life With Electroconvulsive Therapy – A Meta-analysis.

Giacobbe P et al. J ECT. 2018;34(2):87-94

Electroconvulsive Therapy

Espinoza RT, Kellner CH. N Engl J Med. 2022;386(7):667-672

Ketamine versus Electroconvulsive Therapy for Nonpsychotic Treatment-Resistant Major Depression

Anand A, Mathew SJ, Sanacora G, et al. N Engl J Med. 2023;388(25):2315-2325

Ketamine vs Electroconvulsive Therapy for Major Depressive Episode: A Systematic Review and Meta-analysis

Menon V, Varadharajan N, Faheem A, Andrade C. JAMA Psychiatry. 2023;80(6):639-642

Self-Rated ECT Outcomes in Patients With Depression: A Naturalistic Single-Site Study

Berger SR, Kung S, Lapid MI. J ECT. 2025;41(1):39-44

Electroconvulsive Therapy and Age: Age-Related Clinical Features and Effectiveness in Treatment Resistant Major Depressive Episode

Socci C, Medda P, Toni C, et al. J Affect Disord. 2018;227:627-631

ECTECT et trouble bipolaire

▼

Treatment-Resistant Bipolar Depression: A Randomized Controlled Trial of Electroconvulsive Therapy Versus Algorithm-Based Pharmacological Treatment.

Schoeyen HK et al. Am J Psychiatry. 2014;172(1):41-51

Electroconvulsive therapy in bipolar depression – effectiveness and prognostic factors Treatment.

Schoeyen HK et al. Am J Psychiatry. 2014;172(1):41-51

What happens to the course of bipolar disorder after electroconvulsive therapy?

Minnai GP et al. J Affect Disord. 2016;195:180-4

ECT Beyond Unipolar Major Depression: Systematic Review and Meta-Analysis of Electroconvulsive Therapy in Bipolar Depression

Bahji A, Hawken ER, Sepehry AA, Cabrera CA, Vazquez G. Acta Psychiatr Scand. 2019;139(3):214-226

Efficacy and Safety of Electroconvulsive Therapy Plus Medication Versus Medication Alone in Acute Mania: A Meta-Analysis of Randomized Controlled Trials

Zhang J, Wang G, Yang X, Gao K. Psychiatry Res. 2021;302:114027

Association of Clinical and Demographic Characteristics With Response to Electroconvulsive Therapy in Mania

Popiolek K, Bejerot S, Landén M, Nordenskjöld A. JAMA Netw Open. 2022;5(6):e2218406

Electroconvulsive Therapy in Mania: A Review of 80 Years of Clinical Experience

Elias A, Thomas N, Sackeim HA. Am J Psychiatry. 2021;178(3):229-239

ECTECT et schizophrénie

▼

ECT in schizophrenia: a review of the evidence.

Grover S et al. Acta Neuropsychiatr. 2018;31(3):115-127

Electroconvulsive Therapy and Schizophrenia – A Systematic Review

Ali SA et al. Mol Neuropsychiatry. 2019;5(2):75-83

Augmentation of Antipsychotics with Electroconvulsive Therapy in Treatment-Resistant Schizophrenia Patients with Dominant Negative Symptoms: A Pilot Study of Effectiveness.

Pawelczyk T et al. Neuropsychobiology. 2014;70(3):158-64

Electroconvulsive therapy in ultra-resistant schizophrenia – A case series.

Rotharmel M et al. Asian J Psychiatr. 2019;44:6-7

Clinical Effectiveness of Maintenance Electroconvulsive Therapy in Patients with Schizophrenia: A retrospective Cohort Study

Pawelczyk T et al. Neuropsychobiology. 2014;70(3):158-64

Electroconvulsive therapy for treatment-resistant schizophrenia

Sinclair DJ, Zhao S, Qi F, et al. Cochrane Database Syst Rev. 2019;3(3):CD011847

Does Adjunctive Electro-Convulsive Therapy Improve the Speed of Treatment Response in Schizophrenia? A Systematic Review and Week-by-Week Meta-Analyses of Controlled Clinical Trials

Pantoji M, Balachander S, Prajapati P, et al. Schizophr Res. 2025;278:69-79

Electroconvulsive Therapy Added to Non-Clozapine Antipsychotic Medication for Treatment Resistant Schizophrenia: Meta-Analysis of Randomized Controlled Trials

Zheng W, Cao XL, Ungvari GS, et al. PLoS One. 2016;11(6):e0156510

Electroconvulsive Therapy as an Adjunctive Treatment for Clozapine-Resistant Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Barros FMR, Tolentino A, Smaniotto L, et al. J ECT. 2026;42(1):3-11

Randomized, Double-Blind, Sham-Controlled Trial to Evaluate the Efficacy and Tolerability of Electroconvulsive Therapy in Patients With Clozapine-Resistant Schizophrenia

Melzer-Ribeiro DL, Napolitano IC, Leite SA, et al. Schizophr Res. 2024;264:394-401

Clinical Effectiveness and Cognitive Impact of Electroconvulsive Therapy for Schizophrenia: A Large Retrospective Study

Kaster TS, Daskalakis ZJ, Blumberger DM. J Clin Psychiatry. 2017;78(4):e383-e389

Efficacy and Influencing Factors of Modified Electroconvulsive Therapy for Schizophrenia: A Real-World Retrospective Observational Study

Wang Z, Qiu J, Zhang P, Chen M, Wang X. Front Psychiatry. 2025;16:1523456

ECTECT : securité, mécanismes, effets secondaires

▼

Neuropathological evaluation of an 84-year-old man after 422 ECT treatments.

Anderson D et al. J ECT. 2014;30(3):248-50

Electroconvulsive therapy increases temporal gray matter volume and cortical thickness.

Sartorius A et al. Eur Neuropsychopharmacol. 2015;26(3):506-17

Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression: A Systematic Review and Meta-Analysis.

Semkovska M, McLoughlin DM. Biol Psychiatry. 2010;68(6):568-77

Evaluation of cumulative cognitive deficits from electroconvulsive therapy.

Kirov GG et al. Br J Psychiatry. 2015;208(3):266-70

An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System.

Watts BV et al. J ECT. 2011;27(2):105-8

Neurotransmitters and Electroconvulsive Therapy.

Baldinger P et al. J ECT. 2014;30(2):116-21

Hippocampal Neurogenesis and Antidepressive Therapy: Shocking Relations.

Rotheneichner P et al. Neural Plast. 2014;2014:723915

Grey matter volume increase following electroconvulsive therapy in patients with late life depression: a longitudinal MRI study.

Bouckaert F et al. J Psychiatry Neurosci. 2016;41(2):105-14

Effect of electroconvulsive therapy on gray matter volume in major depressive disorder.

Ota M et al. J Affect Disord. 2015;186:186-91

Mechanisms of Antidepressant Response to Electroconvulsive Therapy Studied With Perfusion Magnetic Resonance Imaging.

Leaver AM et al. Biol Psychiatry. 2018;85(6):466-476

Neuromodulation in response to electroconvulsive therapy in schizophrenia and major depression.

Thomann PA et al. Brain Stimul. 2017;10(3):637-644

Long-Term Cognitive and Psychological Functioning in Post–Electroconvulsive Therapy Patients.

Miller ML et al. J ECT. 2019;35(1):27-34

Electroconvulsive therapy and risk of dementia in patients with affective disorders – a cohort study.

Osler M et al. Lancet Psychiatry. 2018;5(4):348-356

ECT : une thérapeutique essentielle en psychiatrie.

Sauvaget A et al. Encephale. 2022;49(1):103-106

KETKétamine et dépression

▼

Interdisciplinary, delphi-driven consensus guidelines on the use of intravenous ketamine infusions for depressive disorders (ASKP3).

Mathai DS, Cluck M, Aslam AM, et al. J Affect Disord. 2026 (online ahead of print)

Ketamine for the treatment of major depression: a systematic review and meta-analysis.

Nikolin S, Rodgers A, Schwaab A, et al. EClinicalMedicine. 2023;62:102127

Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample.

Moore TM et al. J Affect Disord. 2025;381:233-241

Identification of an optimal dose of intravenous ketamine for late-life treatment-resistant depression: a Bayesian adaptive randomization trial.

Lijffijt M et al. Neuropsychopharmacology. 2021;47(5):1088-1095

A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression.

Singh JB et al. Am J Psychiatry. 2016;173(8):816-26

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting

Feifel D et al. J Affect Disord. 2017;221:283-288

Kétamine comme option thérapeutique

Forum Médical Suisse

How club drug ketamine fights depression

Nature

ave drug holds promise for treating depression fast

Nature

ketamine: stimulating antidepressant treatment?

BJPsych Open

Ketamine for treatment-resistant depression: recent developments and clinical applications.

Schwartz J et al. Evid Based Ment Health. 2016;19(2):35-8

NMDAR inhibition-independent antidepressant actions of ketamine metabolites.

Zanos P et al. Nature. 2016;533(7604):481-6

Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.

Pennybaker SJ et al. J Affect Disord. 2016;208:560-566

Administration of ketamine for unipolar and bipolar depression

Kraus C et al. Int J Psychiatry Clin Pract. 2017;21(1):2-12

Efficacy, Safety, and Durability of Repeated Ketamine Infusions for Comorbid Posttraumatic Stress Disorder and Treatment-Resistant Depression. (Journal of Clinical Psychiatry)

Albott CS et al. J Clin Psychiatry. 2018;79(3)

Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity.

Thomas RK et al. J Psychopharmacol. 2018;32(10):1110-1117

Evaluation of the Trajectory of Depression Severity With Ketamine and Esketamine Treatment in a Clinical Setting.

Nikayin S et al. JAMA Psychiatry. 2022;79(7):736-738

Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.

Bahji A et al. J Affect Disord. 2020;278:542-555

KETKétamine dans d’autres indications

▼

Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders – a review of the literature.

Banov MD et al. CNS Spectr. 2019;25(3):331-342

Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder – proof-of-concept

Rodriguez CI et al. Neuropsychopharmacology. 2013;38(12):2475-83

Rapid Resolution of Obsessions After an Infusion of Intravenous Ketamine in a Patient with Treatment-Resistant Obsessive-Compulsive Disorder – A Case Report.

Rodriguez CI et al. J Clin Psychiatry. 2011;72(4):567-9

Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders.

Glue P et al. J Psychopharmacol. 2017;31(10):1302-1305

Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial.

Feder A et al. JAMA Psychiatry. 2014;71(6):681-8

A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder

Feder A, Costi S, Rutter SB, et al. Am J Psychiatry. 2021;178(2):193-202

Effects of Intravenous Ketamine on Posttraumatic Stress Disorder (PTSD): A Systematic Review

Yin L, Lu A, Le GH, et al. Acta Psychiatr Scand. 2026;153(2):140-153

Ketamine for Treatment-Resistant Obsessive-Compulsive Disorder: Double-Blind Active-Controlled Crossover Study

Beaglehole B, Glue P, Neehoff S, et al. J Psychopharmacol. 2025;39(1):23-28

Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-Analysis

Kwan ATH, Lakhani M, Singh G, et al. CNS Spectr. 2024;29(6):531-541

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Taylor JH, Landeros-Weisenberger A, Coughlin C, et al. Neuropsychopharmacology. 2018;43(2):325-333

Effects of Ketamine in Patients With Treatment-Refractory Generalized Anxiety and Social Anxiety Disorders: Exploratory Double-Blind Psychoactive-Controlled Replication Study

Glue P, Neehoff S, Sabadel A, et al. J Psychopharmacol. 2020;34(3):267-272

Ketamine/Esketamine Pharmacotherapy for Treatment of Anxiety Disorders and Anxiety Symptoms in Depression: Systematic Review

Masdrakis VG, Tebbs Z, Natsis V, Baldwin DS. J Psychopharmacol. 2025;39(5):415-430

KETKétamine sans psychothérapie : efficacité des perfusions seules

▼

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review

Veraart JKE, Schimmers N, Breeksema JJ et al. Clin Psychol Rev. 2026;124:102706

Effectiveness of ketamine-assisted psychotherapy as a treatment for treatment-resistant depression: a systematic review

Simpson RJ, Juruena MF. Psychopharmacology (Berl). 2026

Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample

Moore TM, Walker K, Tung E et al. J Affect Disord. 2025;381:233-241

Active mechanisms of ketamine-assisted psychotherapy: A systematic review

Joneborg I, Lee Y, Di Vincenzo JD et al. J Affect Disord. 2022;315:105-112

Cognitive Behavioral Therapy to Sustain the Antidepressant Effects of Ketamine in Treatment-Resistant Depression: A Randomized Clinical Trial

Wilkinson ST, Rhee TG, Joormann J et al. Psychother Psychosom. 2021;90(5):318-327

A/VAudio & vidéo

▼

The Psychedelic Revolution – Don’t Forget About Ketamine

YouTube

TMS en psychiatrie – AP-HM mag flash, Assistance Publique-Hôpitaux de Marseille

YouTube

TMS Brain Stimulation Can Help Combat Depression, Beth Israel Deaconess Medical Center, Boston

YouTube

AVC – Les thérapeutiques par Stimulation Magnétique Transcrânienne, Institut du Cerveau et de la Moelle épinière

YouTube

Ketamine for Treatment-Refractory Depression – Video Interview with James Murrough, MD

YouTube

Des électrochocs contre la dépression. Emission 36,9° du 10.05.2017

Avis d’Experts

L’électricité pour lutter contre la dépression. Emission CQFD du 30.08.2018, RTS La 1ère

RTS

Dépression, de l’ombre à la lumière. Emission Temps Présent du 06.12.2018, RTS1

RTS

La kétamine sur le devant de la scène pour traiter les dépressions résistantes. Le 19H30 du 13.07.2019, RTS1

RTS

Le retour en grâce de la neurostimulation en psychiatrie. Swissinfo.ch, 01.05.2025

Swissinfo

MISCAutres ressources utiles

▼

Consultation de pharmacologie grossesse et allaitement.

ouiiou.com

Thériaque : banque de données sur les médicaments, analyse d’interactions médicamenteuses.

Thériaque

Vous souhaitez en savoir plus ?

Contactez-nous pour discuter des options de traitement adaptées à votre situation.

Nous contacter Adresser un patient

📞 Appeler Adresser un patient

LCIP

Centre de psychiatrie
interventionnelle de Lausanne

Avenue de l'Avant-Poste 4
1005 Lausanne, Suisse

+41 21 320 10 05

© 2026 LCIP — Lausanne, Suisse Confidentialité